Inhalational anthrax due to bioterrorism: Would current centers for disease control and prevention guidelines have identified the 11 patients with inhalational anthrax from october through November 2001?

Clinical Infectious Diseases

Volumn 36, Issue 10, 2003, Pages 1275-1283

  Mayer, Thom A ^a   Morrison, Allan ^a   Bersoff Matcha, Susan ^b   Druckenbrod, Glenn ^a   Murphy, Cecele ^a   Howell, John ^a   Hanfling, Dan ^a   Cates, Robert ^a   Pauze, Denis ^a   Earls, James ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b Division of Infectious Diseases ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; LEVOFLOXACIN;

ANTHRAX; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BLOOD CULTURE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DYSPNEA; ENVIRONMENTAL EXPOSURE; FATIGUE; FEVER; HUMAN; INHALATION; LEUKOCYTE COUNT; MYALGIA; NAUSEA; OCCUPATIONAL EXPOSURE; PHYSICIAN; POLYMERASE CHAIN REACTION; POSTAL MAIL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SWEATING; SYMPTOM; TACHYCARDIA; THORAX RADIOGRAPHY; VOMITING;

ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BIOTERRORISM; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DISEASE OUTBREAKS; ENVIRONMENTAL EXPOSURE; GUIDELINES; HUMANS; INHALATION EXPOSURE; PUBLIC HEALTH PRACTICE; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SPORES, BACTERIAL; UNITED STATES;

EID: 0037846098     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374843     Document Type: Article

References (19)

1. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001; 7:933-44.
2. Mayer TA, Bersoff-Matcha S, Murphy C, et al. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA 2001; 286:2549-53.
3. Borio L, Frank D, Mani V, et al. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA 2001; 286:2554-9.
4. Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002; 8:1-7.
5. Earls J, Cerva D, Berman E, et al. Inhalational anthrax after bioterrorism exposure: spectrum of imaging findings in two surviving patients. Radiology 2002; 222:305-12.
6. Mina B, Dym JP, Kuepper F, et al. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. JAMA 2002; 287:858-62.
7. Barakat LA, Quentzel HL, Jernigan JA, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002; 287:863-8.
8. Bush CM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001; 345:1621-6.
9. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001; 50:941-8.
10. Centers for Disease Control and Prevention. Notice to readers: considerations for distinguishing influenza-like illness from inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001; 50:984-6.
11. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995; 311:376-80.
12. Centers for Disease Control and Prevention. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines. MMWR Morb Mortal Wkly Rep 2001; 50:889-93.
13. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. MMWR Morb Mortal Wldy Rep 2001; 50:909-19.
14. Centers for Disease Control and Prevention. Recommendations for visitors or employees who were in the Hart Senate Buildings on 10/15/01. CDC Health Alert. 18 October 2001.
15. CNN. Anthrax: new case of inhalation. 22 October 2001. Available at: http://www.cnn.com/2001/US/10/21/anx.anthrax.facts/index.html.
16. Lancaster J, Blum J. District postal worker seriously ill. Washington Post. 22 October 2001:1.
17. Lane HC, Fauci AS. Bioterrorism on the home front: a new challenge for American medicine. JAMA 2001; 286:2595-7.
18. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287:2236-52.
19. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA 2002; 287:898-900.